Skip to main content

Table 2 Prevalence of metabolic syndrome according to definition used

From: Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

Definition of MetS used

Prevalence

 

Total

Males

Females

P value

IDF n (%)

159 (45.3)

49 (52.7)

110 (42.6)

0.095

NCEP 2004 n (%)

156 (40.1)

45 (42.5)

111 (39.2)

0.563

NCEP 2001 n (%)

149 (38.3)

42 (40.0)

107 (37.7)

0.676

WHO n (%)

70 (19.4)

25 (25.5)

45 (17.2)

0.075

EGIR n (%)

47 (12.1)

24 (22.6)

23 (8.2)

< 0.001

  1. EGIR = European Group for Insulin Resistance; IDF = International Diabetes Federation; MetS = metabolic syndrome; NCEP = National Cholesterol Education Programme; WHO = World Health Organization.